Charles Schwab Investment Management Inc Vor Biopharma Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 103,918 shares of VOR stock, worth $103,918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,918
Previous 103,918
-0.0%
Holding current value
$103,918
Previous $233,000
5.58%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VOR
# of Institutions
70Shares Held
29MCall Options Held
1.8KPut Options Held
100-
Paradigm Biocapital Advisors LP New York, NY6.46MShares$6.46 Million0.57% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$6.36 Million5.32% of portfolio
-
Laurion Capital Management LP New York, NY3.18MShares$3.18 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$2.25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$1.81 Million0.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $38.1M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...